[1]
A. Raj and A. K. Jha, “Efficacy and safety profile of topical 2% mupirocin vs topical 2% fusidic acid in the treatment of superficial bacterial infections”, Int. J. Heal. Clin. Res., vol. 4, no. 3, pp. 161–163, Feb. 2021.